Gilead Sciences Inc (GILD :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
GILD FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Midday Glance: Biotechnology companies 3 hrs ago - The Associated Press
-
Early Glance: Biotechnology companies 6 hrs ago - The Associated Press
-
Final Glance: Biotechnology companies 22 hrs ago - The Associated Press
-
Midday Glance: Biotechnology companies 23 May 2013 - The Associated Press
-
Early Glance: Biotechnology companies 23 May 2013 - The Associated Press
-
Final Glance: Biotechnology companies 22 May 2013 - The Associated Press
-
Midday Glance: Biotechnology companies 22 May 2013 - The Associated Press
-
-
Early Glance: Biotechnology companies 22 May 2013 - The Associated Press
MORE FROM OUR PARTNERS
-
Cramer's Mad Money - The Miraculous Six Flags (5/22/13) 23 May 2013 - Seeking Alpha
-
Tiger Cub John Griffin's Top Stock Picks For Q2 22 May 2013 - Seeking Alpha
-
Will Influenza A H7N9 Generate Opportunities For Pharma? 21 May 2013 - Seeking Alpha
-
Cramer's Mad Money - The Kids Love Tesla (5/20/13) 21 May 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare... 20 May 2013 - Seeking Alpha
-
Gilead Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcr... 02 May 2013 - Seeking Alpha
PRESS RELEASES
-
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan ... 9 hrs ago - PR Newswire
-
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 23 May 2013 - PR Newswire
-
NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 21 May 2013 - PR Newswire
-
European Medicines Agency Validates Gilead's Marketing Application for... 21 May 2013 - Business Wire
-
Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire
-
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire
-
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cas... 20 May 2013 - PR Newswire
-
HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Suppo... 20 May 2013 - PR Newswire
-
eFFECTOR Therapeutics Raises $45 Million in Series A Financing 20 May 2013 - PR Newswire
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conferenc... 17 May 2013 - Business Wire
